Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting - Saha, Sanjib; Gerdtham, Ulf-Göran; Sjödahl, Gottfrid; Häggström, Christel; Catto, James W. F.; Kelly, John D.; Ullén, Anders; Holmberg, Lars; Liedberg, Fredrik; Lund University, Profile areas and other strong research environments, Lund University Profile areas, LU Profile Area: Proactive Ageing, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Lunds universitets profilområden, LU profilområde: Proaktivt åldrande, Originator; Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator; Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Health Economics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Hälsoekonomi, Originator; et al. (Frontiers in Oncology, 2025)